{"title":"美国患有阿片类药物使用障碍的育儿妇女接受行为健康治疗的情况。","authors":"Stacey E. Iobst, Priscilla Novak, Mir M. Ali","doi":"10.1016/j.jogn.2024.01.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To examine use of mental health treatment, substance use disorder treatment, and perceived barriers to treatment by whether a major depressive episode occurred during the past year among parenting women with opioid use disorder.</p></div><div><h3>Design</h3><p>Secondary analysis of survey data from the National Survey on Drug Use and Health, 2015–2019.</p></div><div><h3>Setting</h3><p>United States.</p></div><div><h3>Participants</h3><p>Women aged 18 to 44 years with opioid use disorder and at least one child in the household.</p></div><div><h3>Methods</h3><p>We computed descriptive statistics for demographic characteristics, treatment by major depressive episode status, and barriers to treatment by major depressive episode status. We conducted multinomial logistic regression to examine associations among demographic characteristics, major depressive episode status, and type of treatment.</p></div><div><h3>Results</h3><p>Of the 36% of respondents in our weighted sample (<em>N</em> ≈ 254,300) who experienced major depressive episode, 35% received substance use disorder and mental health treatment, and 27% did not receive any form of treatment. We found that identification as a person of color was significantly associated with a lower relative risk of receiving any type of treatment. Frequently reported barriers to treatment included affordability, access, and stigma.</p></div><div><h3>Conclusion</h3><p>Respondents with opioid use disorder and co-occurring major depressive episode did not obtain necessary treatment. Barriers to treatment, including affordability, access to treatment, and stigma, need to be addressed, particularly among women of color.</p></div>","PeriodicalId":54903,"journal":{"name":"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing","volume":"53 4","pages":"Pages 355-367"},"PeriodicalIF":1.8000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of Behavioral Health Treatment Among Parenting Women With Opioid Use Disorder in the United States\",\"authors\":\"Stacey E. Iobst, Priscilla Novak, Mir M. Ali\",\"doi\":\"10.1016/j.jogn.2024.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To examine use of mental health treatment, substance use disorder treatment, and perceived barriers to treatment by whether a major depressive episode occurred during the past year among parenting women with opioid use disorder.</p></div><div><h3>Design</h3><p>Secondary analysis of survey data from the National Survey on Drug Use and Health, 2015–2019.</p></div><div><h3>Setting</h3><p>United States.</p></div><div><h3>Participants</h3><p>Women aged 18 to 44 years with opioid use disorder and at least one child in the household.</p></div><div><h3>Methods</h3><p>We computed descriptive statistics for demographic characteristics, treatment by major depressive episode status, and barriers to treatment by major depressive episode status. We conducted multinomial logistic regression to examine associations among demographic characteristics, major depressive episode status, and type of treatment.</p></div><div><h3>Results</h3><p>Of the 36% of respondents in our weighted sample (<em>N</em> ≈ 254,300) who experienced major depressive episode, 35% received substance use disorder and mental health treatment, and 27% did not receive any form of treatment. We found that identification as a person of color was significantly associated with a lower relative risk of receiving any type of treatment. Frequently reported barriers to treatment included affordability, access, and stigma.</p></div><div><h3>Conclusion</h3><p>Respondents with opioid use disorder and co-occurring major depressive episode did not obtain necessary treatment. Barriers to treatment, including affordability, access to treatment, and stigma, need to be addressed, particularly among women of color.</p></div>\",\"PeriodicalId\":54903,\"journal\":{\"name\":\"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing\",\"volume\":\"53 4\",\"pages\":\"Pages 355-367\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0884217524000042\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NURSING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0884217524000042","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NURSING","Score":null,"Total":0}
Use of Behavioral Health Treatment Among Parenting Women With Opioid Use Disorder in the United States
Objective
To examine use of mental health treatment, substance use disorder treatment, and perceived barriers to treatment by whether a major depressive episode occurred during the past year among parenting women with opioid use disorder.
Design
Secondary analysis of survey data from the National Survey on Drug Use and Health, 2015–2019.
Setting
United States.
Participants
Women aged 18 to 44 years with opioid use disorder and at least one child in the household.
Methods
We computed descriptive statistics for demographic characteristics, treatment by major depressive episode status, and barriers to treatment by major depressive episode status. We conducted multinomial logistic regression to examine associations among demographic characteristics, major depressive episode status, and type of treatment.
Results
Of the 36% of respondents in our weighted sample (N ≈ 254,300) who experienced major depressive episode, 35% received substance use disorder and mental health treatment, and 27% did not receive any form of treatment. We found that identification as a person of color was significantly associated with a lower relative risk of receiving any type of treatment. Frequently reported barriers to treatment included affordability, access, and stigma.
Conclusion
Respondents with opioid use disorder and co-occurring major depressive episode did not obtain necessary treatment. Barriers to treatment, including affordability, access to treatment, and stigma, need to be addressed, particularly among women of color.
期刊介绍:
JOGNN is a premier resource for health care professionals committed to clinical scholarship that advances the health care of women and newborns. With a focus on nursing practice, JOGNN addresses the latest research, practice issues, policies, opinions, and trends in the care of women, childbearing families, and newborns.
This peer-reviewed scientific and technical journal is highly respected for groundbreaking articles on important - and sometimes controversial - issues. Articles published in JOGNN emphasize research evidence and clinical practice, building both science and clinical applications. JOGNN seeks clinical, policy and research manuscripts on the evidence supporting current best practice as well as developing or emerging practice trends. A balance of quantitative and qualitative research with an emphasis on biobehavioral outcome studies and intervention trials is desired. Manuscripts are welcomed on all subjects focused on the care of women, childbearing families, and newborns.